Peter Verdult

Stock Analyst at Citigroup

(0.42)
# 4,240
Out of 5,112 analysts
6
Total ratings
33.33%
Success rate
-14.18%
Average return

Stocks Rated by Peter Verdult

Eli Lilly and Company
Nov 12, 2025
Maintains: Buy
Price Target: $1,250$1,500
Current: $1,056.88
Upside: +41.93%
Evotec SE
Jun 8, 2023
Upgrades: Buy
Price Target: n/a
Current: $2.93
Upside: -
Galapagos NV
Jan 27, 2022
Upgrades: Buy
Price Target: n/a
Current: $31.63
Upside: -